Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process LEXINGTON, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. ("Keros" or the "Company") (Nasdaq: KROS) ...

U.S. FDA Grants Full Approval of VITRAKVI® (larotrectinib) for Adult and Pediatric Patients with NTRK Gene Fusion-Positive ...

Use this blood pressure chart to interpret your blood pressure readings and monitor this important heart health metric from ...

Converting from the long-acting ESA methoxy polyethylene glycol-epoetin-ß (MPG-EPO) to thrice weekly vadadustat is feasible for the hemodialysis population.